Atrial natriuretic peptide increases glucose uptake during hypoxia in cardiomyocytes

Journal of Cardiovascular Pharmacology

Volumn 40, Issue 4, 2002, Pages 601-610

  Kudoh, Akira ^a   Katagai, Hiroshi ^a   Takazawa, Tomoko ^a  

^a HIROSAKI NATIONAL HOSPITAL   (Japan)

Author keywords

Atrial natriuretic peptide; Cardiomyocytes; Glucose uptake; Hypoxia; Phospholipase C; Tyrosine kinase

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; ATRIAL NATRIURETIC FACTOR; CALCIUM ION; GENISTA EXTRACT; GLUCOSE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; TYRPHOSTIN;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL CULTURE; CONTROLLED STUDY; ENZYME ASSAY; ENZYME INHIBITION; GLUCOSE TRANSPORT; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HORMONE ACTION; HYPOXIA; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ATRIAL NATRIURETIC FACTOR; CELL HYPOXIA; CELLS, CULTURED; GLUCOSE; MYOCYTES, CARDIAC; RATS;

EID: 0036785773     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200210000-00014     Document Type: Article

References (26)

1. Tahiliani AG. In: The heart and cardiovascular system: scientific foundations. 2nd ed. Fozzard HA, Haber E, Jenings RB, et al., eds. New York: Raven Press, 1992:1599-1620.
2. Owen P, Dennis S, Opie LH. Glucose flux rate regulates onset of ischemic contracture in globally underperfused rat hearts. Circ Res 1990;66:344-54.
3. Mallet RT, Hartman DA, Bunger R. Glucose requirement for postischemic recovery of perfused working heart. Eur J Biochem 1990;188:481-93.
4. Steinberg SF, Alter A. Enhanced receptor-dependent inositol trisphosphate accumulation in hypoxic myocytes. Am J Physiol 1993;265:H691-9.
5. Henriksen E, Rodnick K, Holloszy J. Activation of glucose transport in skeletal muscle by phospholipase C and phorbol ester. J Biol Chem 1989;264:21536-43.
6. Kahn CR. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 1994;43:1066-84.
7. Chen YF, Durand J, Claycomb WC. Hypoxia stimulates atrial natriuretic peptide gene expression in cultured arterial cardiocytes. Hypertension 1997;29:75-82.
8. Ljusegren ME, Andersson RG. Protective effect of atrial natriuretic peptide on electrical-field-stimulated rat ventricular strips during hypoxia. Pharmacol Toxicol 1994;75: 337-432.
9. Semigran MJ, Aroney CN, Herrmann HC, et al. Effects of atrial natriuretic peptide on myocardial contractile and diastolic function in patients with heart failure. J Am Coll Cardiol 1992;20:98-106.
10. Takata Y, Hirayama Y, Kiyomi S, et al. The beneficial effects of atrial natriuretic peptide on arrhythmias and myocardial high-energy phosphate after reperfusion. Cardiovasc Res 1996;32:286-93.
11. Uusimaa PA, Peuhkurinen KJ, Vuolteenaho O, et al. Role of myocardial redox and energy states in ischemia-stimulated release of atrial natriuretic peptide. J Mol Cell Cardiol 1992;24:191-205.
12. Sadoshima J, Jahn L, Takahashi T, et al. Molecular characterization of the stretch-induced adaptation of cultured cardiac cells: an in vitro model of load-induced cardiac hypertrophy. J Biol Chem 1992 May 25;267:10551-60.
13. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
14. Rhee SG. Inositol phospholipid-specific phospholipase C: interaction of the μ1 isoform with tyrosine kinase. Trends Biochem Sci 1991;16:297-301.
15. 2+ channel activity by human natriuretic peptide in rabbit heart cells. Br J Pharmacol 1995;114:1076-82.
16. 2+-calmodulin mediated modulation of the electrical coupling of ventricular myocytes isolated from guinea pig heart. J Mol Cell Cardiol 1994;26:1007-15.
17. Neyses L, Vetter H. Action of atrial natriuretic peptide and angiotensin II on the myocardium: studies in isolated rat ventricular cardiomyocytes. Biochem Biophys Res Commun 1989;163:1435-43.
18. Brock TA, Rittenhouse SE, Powers CW, et al. Phorbol ester and 1-oleoyl-2-acetylglycerol inhibit angiotensin activation of phospholipase C in cultured vascular smooth muscle cells. J Biol Chem 1985;260:14158-62.
19. Bianciotti LG, Vatta MS, Elverdin JC, et al. Atrial natriuretic factor-induced amylase output in the rat parotid gland appears to be mediated by the inositol phosphate pathway. Biochem Biophys Res Commun 1998;247:123-8.
20. Standaert ML, Avignon A, Yamada K, et al. The phosphatidylinositol 3-kinase inhibitor, wortmannin, inhibits insulin-induced activation of phosphatidylcholine hydrolysis and associated protein kinase C translocation in rat adipocytes. Biochem J 1996;313:1039-46.
21. Bleasdale J, Thakur N, Gremban R. Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neurotrophils. J Pharmacol Exp Ther 1990;256:756-68.
22. Powis G, Bonjouklian R, Berggren MM. Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. Cancer Res 1994;54:2419-23.
23. Fasolato C, Pizzo P, Pozzan T. Receptor-mediated calcium influx in PC12 cells: ATP and bradykinin activate independent pathways. J Biol Chem 1990;265:20351-5.
24. Northover BJ. Effects of 8-(N,N-diethylamino)octyl 3,4,5-trimethoxybenzoate (TMB8) on rat atrial muscle. Biochem Pharmacol 1992;44:425-32.
25. Spieckermann PG, Piper HM. Oxygen demand of calcium-tolerant adult cardiac myocytes. Basic Res Cardiol 1985;80:71-4.
26. Depre C, Rider MH, Veitch K, et al. Role of fructose 2,6-bisphosphate in the control of heart glycolysis. J Biol Chem 1993;268:13274-9.